![Atsushi Sakano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mr. Atsushi Sakano is a Chief Investment Officer at Tenucia Partners Ltd. Mr. Sakano was previously employed as a Partner by Aspex Management (HK) Ltd.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Innovacell KK
 Innovacell KK BiotechnologyHealth Technology Develops cell therapies for treating fecal and stress urinary incontinence 3,64% | 24/02/2026 | 1 643 914 ( 3,64% ) | 6 M $ | 31/08/2026 |
Postes actifs de Atsushi Sakano
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Atsushi Sakano
| Sociétés | Poste | Fin |
|---|---|---|
Aspex Management (HK) Ltd.
 Aspex Management (HK) Ltd. Investment ManagersFinance Aspex Management invests in companies located in Asia. The firm targets companies operating across a broad range of sectors. It provides financing for growth transactions. | Private Equity Investor | 31/03/2025 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Aspex Management (HK) Ltd.
Aspex Management (HK) Ltd. Investment ManagersFinance Aspex Management invests in companies located in Asia. The firm targets companies operating across a broad range of sectors. It provides financing for growth transactions. | Finance |
